The Directors team at Immunomic Therapeutics, Inc. provides strategic leadership and governance, ensuring the company advances its clinical-stage biotechnology innovations. They oversee various functions, including research, development, regulatory affairs, and finance, to drive the success of the UNITE nucleic acid immunotherapy platform.